Maspin was shown to inhibit the motility and invasion of tumor cells in in vitro breast/prostate cancer cell lines and it reduces the capacity for tumor development and metastasis of cancer cell lines in animal models [9,10,11,12]. This evidence concerns the gene SERPINB5 and prostate cancer.